Effect of different doses of losartan on treatment of diabetic nephropathy
Cheng De-zheng
Abstract
Cheng De-zheng
Abstract
Objective:To explore the effects of different doses of losartan on the treatment of diabetic nephropathy.Methods:120 cases of diabetic kidney were randomly divided into three groups for strict diabetes treatment.Group A,B and C were given losartan in a dose of 25,50,100 mg/(time.d) respectively.After 8-week treatment,serum creatinine(SCr),urinary albumin excretion rate(UAER),crea-tinine clearance rate(CCr) and lipids were detected in three groups.Results:After treatment,UAER,TC and TG were reduced significantly in the three groups(P0.05);between group B and A,group C and A the differences were statistically significant(P0.05);However,group B and C had no statistically significant difference.SCr in three groups before and after treatment had no statistical difference.The level of CCr had statistical differences before and after treatment(P0.05),but group C and A had statistical difference(P0.05).Conclusion: Losartan is safe,effective and well tolerated with no significant adverse reactions for treating diabetic nephropathy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the effects of different doses of losartan on the treatment of diabetic nephropathy.Methods:120 cases of diabetic kidney were randomly divided into three groups for strict diabetes treatment.Group A,B and C were given losartan in a dose of 25,50,100 mg/(time.d) respectively.After 8-week treatment,serum creatinine(SCr),urinary albumin excretion rate(UAER),crea-tinine clearance rate(CCr) and lipids were detected in three groups.Results:After treatment,UAER,TC and TG were reduced significantly in the three groups(P0.05);between group B and A,group C and A the differences were statistically significant(P0.05);However,group B and C had no statistically significant difference.SCr in three groups before and after treatment had no statistical difference.The level of CCr had statistical differences before and after treatment(P0.05),but group C and A had statistical difference(P0.05).Conclusion: Losartan is safe,effective and well tolerated with no significant adverse reactions for treating diabetic nephropathy.
Key concepts: Medicine, Losartan, Diabetic nephropathy, Urology, Creatinine, Diabetes mellitus, Internal medicine, Excretion